Evidence map›Paper›PMID 41450408›Full record

ArticleCureus2025

Recurrent Hematocolpos and Hematometra as a Late Complication of Endometrial Ablation: A Case Report.

Fatima Hameed, Rabeet Hassan, Asiya Alvi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatima HameedObstetrics and Gynecology, Bolton NHS Foundation Trust, Manchester, GBR.
Rabeet HassanPediatric Endocrinology, Indus Hospital Network, Lahore, PAK.
Asiya AlviObstetrics and Gynecology, Bolton NHS Foundation Trust, Manchester, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial ablation functions as a minimally invasive procedure to treat heavy menstrual bleeding when other treatments prove ineffective. The procedure maintains safety for most patients, yet they may experience delayed complications, which include obstructive issues such as hematometra and hematocolpos. We present the case of a 48-year-old patient who developed recurring symptomatic hematocolpos and hematometra three months following her endometrial ablation procedure for treating excessive menstrual bleeding. The patient experienced periodic lower abdominal discomfort, which imaging tests, including pelvic transvaginal ultrasound, CT scan, and MRI, confirmed resulted in hematometra. The patient underwent two drainage procedures under general anesthesia. The patient underwent a hysterectomy after a third occurrence of identical symptoms through a shared decision-making process. The histopathological examination revealed intrauterine fibrosis and cervical canal blockage, but no evidence of cancer. This case illustrates an unusual yet crucial complication that occurs following endometrial ablation treatments. Medical staff must recognize cyclic pelvic pain and amenorrhea as warning indicators of obstructive pathology to provide timely treatment. The management of this condition requires a systematic treatment approach that starts with observation and pain management before advancing to hysteroscopic revision. The first step in managing obstructive pathology requires complete imaging through transvaginal ultrasound and MRI when needed to assess the degree of anatomical blockages. The initial approach for treating obstructive pathology involves monitoring the patient while providing pain management through conservative methods. The treatment plan shifts to hysteroscopic revision as a minimally invasive procedure after conservative approaches fail to deliver sustained results. The patient needs a hysterectomy as their last treatment option after both conservative and hysteroscopic methods fail to deliver symptom relief. The selection of surgical treatment depends on how severe the symptoms are and how long they persist, as well as the extent of fibrosis and anatomical blockage severity, and the patient's desire to keep their uterus. Medical practitioners need to evaluate post-ablation hematometra or hematocolpos in women who present with cyclic pelvic pain and amenorrhea. The prevention of morbidity requires immediate imaging tests along with prompt medical interventions.

Indexed as

cyclical abdominal painheavy menstrual bleedinghematocolposradiofrequency ablationusg-guided hematometra drainage

Identifiers

PMID41450408
PMCPMC12728442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.